Evidence map›Paper›PMID 31237767›Full record

ArticleAmerican journal of rhinology & allergy2019

Differential Expression of Extracellular Matrix Components in Nasal Polyp Endotypes.

Xin Feng, Spencer C Payne, Larry Borish, John W Steinke

Abstract read
In one paragraph

Article in American journal of rhinology & allergy, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Residual nasal polyp tissue following dupilumab therapy is associated with periostin-associated fibrosis.European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery · 2024
    Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Xin FengDepartment of Otorhinolaryngology, QiLu Hospital of Shandong University, Jinan, China.
Spencer C PayneAsthma and Allergic Disease Center, University of Virginia Health System, Charlottesville, Virginia.
Larry BorishAsthma and Allergic Disease Center, University of Virginia Health System, Charlottesville, Virginia.
John W SteinkeAsthma and Allergic Disease Center, University of Virginia Health System, Charlottesville, Virginia.ORCID https://orcid.org/0000-0003-4571-8473

Funding

An Evaluation of Treatment with Omalizumab to Improve the Asthmatic Response to aU01AI100799 · NIAID · UNIVERSITY OF VIRGINIA · PI HEYMANN, PETER W, PLATTS-MILLS, THOMAS A. · 2012 to 2015
$5.3M
Interplay between LTE4/LTE4 receptors and IFN-y with mast cells and eosinophils iR01AI057438 · NIAID · UNIVERSITY OF VIRGINIA · PI BORISH, LARRY C · 2006 to 2015
$3.7M
Clinical response to rhinovirus challenge in human asthmaticsU01AI123337 · NIAID · UNIVERSITY OF VIRGINIA · PI BORISH, LARRY C · 2016 to 2020
$3.6M
NIAID NIH HHS R01 AI057438NIAID NIH HHS U01 AI100799NIAID NIH HHS U01 AI123337
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Chronic DiseaseCollagen Type IIIEosinophilsExtracellular MatrixFibronectinsFluorescent Antibody TechniqueGene Expression RegulationHumansImmunohistochemistryLeukocyte CountNasal PolypsParanasal SinusesPhenotypeRhinitisSinusitisCollagen Type IIIFibronectinsallergic fungal sinusitisaspirin-exacerbated respiratory diseasechronic rhinosinusitiscollageneosinophilsextracellular matrixfibronectinlamininnasal polypsvessels

Identifiers

PMID31237767
PMCPMC6843742

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.